Skip to main content
S 1548 117th Congress Senate Health Congressional oversight Health facilities and institutions Health programs administration and funding Health promotion and preventive care Higher education Medical research Minority education Minority employment Minority health Neurological disorders Research administration and funding

ENACT Act of 2021

Introduced: May 11, 2021 Introduced by: Luján, Ben Ray Democratic · New Mexico See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 11, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 11, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 or the ENACT Act of 2021

This bill sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimer's disease and related dementias.

Specifically, the National Institute on Aging (NIA) must establish and provide technical assistance to Alzheimer's research centers located in areas with higher concentrations of minority groups. These centers must

  • establish diagnostic and treatment clinics designed to serve minority, rural, and other underserved populations;
  • operate clinical trials; and
  • carry out public outreach to encourage members of minority populations to participate in clinical trials and research.

Additionally, the NIA must disseminate information to members of minority populations about participating in clinical trials and take other actions to enhance diversity with respect to the Alzheimer's research that it conducts or supports.

The bill also directs the NIA to increase diversity among Alzheimer's researchers by encouraging the participation of individuals who are from groups that are underrepresented in clinical, behavioral, and social sciences.

What's happening now May 11, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1548: ENACT Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-1548/
MLA
"S. 1548: ENACT Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-1548/.
Bluebook (legal)
S. 1548, 117th Cong. (2026), https://openamerica.io/bill/117-S-1548/.
Markdown link
[S. 1548: ENACT Act of 2021](https://openamerica.io/bill/117-S-1548/)
Report a problem